Breadcrumb

Breadcrumbs

Press Releases

Press Releases

News, Events, Updates, Breakthroughs

Press announcements are archived by release date, searchable by topic:

From To
Date Title
Wed Jan 18 00:00:00 GMT-04:00 2017
Daiichi Sankyo Initiates Phase 1/2 Study of Novel Antibody Drug Conjugate U3-1402 in Patients with ...
PDF (178 KB)
Mon Dec 12 00:00:00 GMT-04:00 2016
Daiichi Sankyo and DarwinHealth Announce Strategic Partnership to Deploy a Quantitative Systems Bio ...
PDF (163 KB)
Mon Dec 05 00:00:00 GMT-04:00 2016
Daiichi Sankyo Presents Phase 1 Data for MDM2 Inhibitor DS-3032 in Acute Myeloid Leukemia and Myelo ...
PDF (193 KB)
Thu Dec 01 00:00:00 GMT-04:00 2016
U.S. FDA Grants Fast Track Designation for HER2-Targeting Antibody Drug Conjugate DS-8201 for HER2- ...
PDF (180 KB)
Wed Nov 30 00:00:00 GMT-04:00 2016
Daiichi Sankyo Highlights Clinical Data of Two Novel Hematological Agents at the 58th Annual Meetin ...
PDF (178 KB)
Mon Nov 07 00:00:00 GMT-04:00 2016
Daiichi Sankyo Announces New Subgroup Analyses of Once-Daily SAVAYSA® (edoxaban) in Patients with N ...
PDF (367 KB)
Tue Oct 25 00:00:00 GMT-04:00 2016
Daiichi Sankyo, Inc. and Inspirion Delivery Sciences LLC Announce U.S. Licensing Agreement for Morp ...
PDF (349 KB)
Tue Oct 25 00:00:00 GMT-04:00 2016
Anti-HER3 Monoclonal Antibody Patritumab Selected for I-SPY 2 TRIAL in Breast Cancer
PDF (143 KB)
Fri Oct 21 00:00:00 GMT-04:00 2016
ENLIVEN Phase 3 Study of Pexidartinib in Tenosynovial Giant Cell Tumor (TGCT) Will Continue to Comp ...
PDF (161 KB)
Wed Oct 12 00:00:00 GMT-04:00 2016
Daiichi Sankyo and Dana-Farber Cancer Institute Announce Lung Cancer Research Collaboration
PDF (135 KB)
Showing 1 - 10 of 26 results.

Press Release More Stories

More Stories

Who We Are

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability..

read more ...